The efficacy and safety of osimertinib in patients with advanced EGFR-mutated NSCLC: a systematic review and meta-analysis of randomized controlled trials

被引：0
|
作者：
Tang, Xiumei [1 ]
Li, Weimin [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA4756
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of osimertinib for patients with EGFR-mutated NSCLC: a systematic review and meta-analysis of randomized controlled studies
    Li, Li
    Huang, Qin
    Sun, Jianhai
    Yan, Fei
    Wei, Wujie
    Li, Zihui
    Liu, Li
    Deng, Jie
    ACTA ONCOLOGICA, 2022, 61 (11) : 1347 - 1353
  • [2] Efficacy and safety of osimertinib in treating EGFR-mutated advanced NSCLC: A meta-analysis
    Yi, Lilan
    Fan, Junsheng
    Qian, Ruolan
    Luo, Peng
    Zhang, Jian
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (01) : 284 - 294
  • [3] CNS efficacy of osimertinib in EGFR-mutated advanced NSCLC
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2018, 19 (10): : E516 - E516
  • [4] Osimertinib in EGFR-Mutated Advanced NSCLC
    Revannasiddaiah, Swaroop
    Devadas, Santhosh K.
    Maka, Vinayak V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19): : 1864 - 1864
  • [5] Safety and efficacy of osimertinib in patients with NSCLC and uncommon tumoral EGFR mutations: A systematic review and meta-analysis
    Priantti, Jonathan N.
    Vilbert, Maysa
    Moraes, Francisco Cezar A.
    Michelon, Isabella
    Castro, Caio
    Leighl, Natasha B.
    Cavalcante, Ludimila
    Fujiwara, Yu
    Addeo, Alfredo
    Bar, Jair
    Cortellini, Alessio
    Nassar, Amin
    Naqash, Abdul Rafeh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
    Planchard, D.
    Janne, P. A.
    Cheng, Y.
    Yang, J. C. -H.
    Yanagitani, N.
    Kim, S-W
    Sugawara, S.
    Yu, Y.
    Fan, Y.
    Geater, S. L.
    Laktionov, K.
    Lee, C. K.
    Valdiviezo, N.
    Ahmed, S.
    Maurel, J-M
    Andrasina, I
    Goldman, J.
    Ghiorghiu, D.
    Rukazenkov, Y.
    Todd, A.
    Kobayashi, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (21): : 1935 - 1948
  • [7] Safety of Readministration of EGFR-TKI After Onset of Interstitial Lung Disease in Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis
    Kashizaki, Fumihiro
    Chen, Hao
    Miyasaka, Atsushi
    Tsuchiya, Nanami
    Yamada, Chihiro
    Okazaki, Shunsuke
    Kaneko, Mai
    Kano, Taiki
    Kameda, Yohei
    Kikuchi, Akitomo
    Yumoto, Kentaro
    Osawa, Hiroyuki
    Koizumi, Harumi
    Takahashi, Kenichi
    Kaneko, Takeshi
    CLINICAL LUNG CANCER, 2024, 25 (01) : e52 - e57.e2
  • [8] The efficacy and safety of furmonertinib in patients with advanced EGFR-mutated NSCLC and leptomeningeal metastases
    Han, Huan
    Tang, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
    Ramalingam, S. S.
    Vansteenkiste, J.
    Planchard, D.
    Cho, B. C.
    Gray, J. E.
    Ohe, Y.
    Zhou, C.
    Reungwetwattana, T.
    Cheng, Y.
    Chewaskulyong, B.
    Shah, R.
    Cobo, M.
    Lee, K. H.
    Cheema, P.
    Tiseo, M.
    John, T.
    Lin, M-C
    Imamura, F.
    Kurata, T.
    Todd, A.
    Hodge, R.
    Saggese, M.
    Rukazenkov, Y.
    Soria, J-C
    Boyer, Michael
    Lee, Chee
    Hughes, Brett
    O'Byrne, Kenneth
    Briggs, Peter
    Milward, Michael
    John, Thomas
    Demedts, Ingel
    Vansteenkiste, Johan
    Bustin, Frederique
    Barrios, Carlos Henrique
    Timcheva, Constanta
    Butts, Charles
    Goss, Glenwood
    Juergens, Rosalyn
    Leighl, Natasha
    Cheng, Susanna
    Burkes, Ronald
    Zhou, Caicun
    Zhang, Helong
    Shu, Yongqian
    Cheng, Ying
    Zhou, Qing
    Li, Wei
    Feng, Guosheng
    He, Yong
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 41 - 50
  • [10] Comparative Efficacy and Safety of TKIs Alone or in Combination With Antiangiogenic Agents in Advanced EGFR-Mutated NSCLC as the First-Line Treatment: A Systematic Review and Meta-Analysis
    Zhang, Shuang
    Li, Shuang
    Liu, Jingjing
    Yang, Changliang
    Zhang, Liang
    Bao, Hao
    Cheng, Ying
    CLINICAL LUNG CANCER, 2022, 23 (02) : 159 - 169
12345